ロード中...
PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis
Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignant disease with 5-year survival rate of less than 6%. Activating mutations of Kras (mu-Kras) are often detected in most of PDAC patients. Although it has been known that oncogenic Kras is the driver of pancreatic cancer initiation and develop...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6132349/ https://ncbi.nlm.nih.gov/pubmed/30214681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25127 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|